308 related articles for article (PubMed ID: 26183527)
1. SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells.
Piao L; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
Oncotarget; 2015 Jul; 6(19):16939-50. PubMed ID: 26183527
[TBL] [Abstract][Full Text] [Related]
2. Automethylation of SUV39H2, an oncogenic histone lysine methyltransferase, regulates its binding affinity to substrate proteins.
Piao L; Nakakido M; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
Oncotarget; 2016 Apr; 7(16):22846-56. PubMed ID: 26988914
[TBL] [Abstract][Full Text] [Related]
3. LSD1 demethylase and the methyl-binding protein PHF20L1 prevent SET7 methyltransferase-dependent proteolysis of the stem-cell protein SOX2.
Zhang C; Hoang N; Leng F; Saxena L; Lee L; Alejo S; Qi D; Khal A; Sun H; Lu F; Zhang H
J Biol Chem; 2018 Mar; 293(10):3663-3674. PubMed ID: 29358331
[TBL] [Abstract][Full Text] [Related]
4. LSD1 knockdown reveals novel histone lysine methylation in human breast cancer MCF-7 cells.
Jin Y; Huo B; Fu X; Cheng Z; Zhu J; Zhang Y; Hao T; Hu X
Biomed Pharmacother; 2017 Aug; 92():896-904. PubMed ID: 28601046
[TBL] [Abstract][Full Text] [Related]
5. Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis.
Zeng Y; Qiu R; Yang Y; Gao T; Zheng Y; Huang W; Gao J; Zhang K; Liu R; Wang S; Hou Y; Yu W; Leng S; Feng D; Liu W; Zhang X; Wang Y
Cell Rep; 2019 Nov; 29(6):1482-1498.e4. PubMed ID: 31693890
[TBL] [Abstract][Full Text] [Related]
6. Lysine methylation regulates E2F1-induced cell death.
Kontaki H; Talianidis I
Mol Cell; 2010 Jul; 39(1):152-60. PubMed ID: 20603083
[TBL] [Abstract][Full Text] [Related]
7. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
[TBL] [Abstract][Full Text] [Related]
8. Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.
Jin L; Hanigan CL; Wu Y; Wang W; Park BH; Woster PM; Casero RA
Biochem J; 2013 Jan; 449(2):459-68. PubMed ID: 23072722
[TBL] [Abstract][Full Text] [Related]
9. LSD1 collaborates with EZH2 to regulate expression of interferon-stimulated genes.
Jin Y; Huo B; Fu X; Hao T; Zhang Y; Guo Y; Hu X
Biomed Pharmacother; 2017 Apr; 88():728-737. PubMed ID: 28152483
[TBL] [Abstract][Full Text] [Related]
10. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology.
Lim S; Janzer A; Becker A; Zimmer A; Schüle R; Buettner R; Kirfel J
Carcinogenesis; 2010 Mar; 31(3):512-20. PubMed ID: 20042638
[TBL] [Abstract][Full Text] [Related]
11. Methylation-mediated regulation of E2F1 in DNA damage-induced cell death.
Xie Q; Bai Y; Wu J; Sun Y; Wang Y; Zhang Y; Mei P; Yuan Z
J Recept Signal Transduct Res; 2011 Apr; 31(2):139-46. PubMed ID: 21320024
[TBL] [Abstract][Full Text] [Related]
12. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
[TBL] [Abstract][Full Text] [Related]
13. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
Laurent B; Shi Y
Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
[TBL] [Abstract][Full Text] [Related]
14. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
Metzger E; Wissmann M; Yin N; Müller JM; Schneider R; Peters AH; Günther T; Buettner R; Schüle R
Nature; 2005 Sep; 437(7057):436-9. PubMed ID: 16079795
[TBL] [Abstract][Full Text] [Related]
15. Activity and specificity of the human SUV39H2 protein lysine methyltransferase.
Schuhmacher MK; Kudithipudi S; Kusevic D; Weirich S; Jeltsch A
Biochim Biophys Acta; 2015 Jan; 1849(1):55-63. PubMed ID: 25459750
[TBL] [Abstract][Full Text] [Related]
16. Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2).
Mino K; Nishimura S; Ninomiya S; Tujii H; Matsumori Y; Tsuchida M; Hosoi M; Koseki K; Wada S; Hasegawa M; Sasaki R; Murakami-Yamaguchi Y; Narita H; Suzuki T; Miyata N; Mizukami T
Biosci Biotechnol Biochem; 2014; 78(6):1010-7. PubMed ID: 25036127
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
Hosseini A; Minucci S
Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367
[TBL] [Abstract][Full Text] [Related]
18. Visualizing the histone code on LSD1.
Gamble MJ; Kraus WL
Cell; 2007 Feb; 128(3):433-4. PubMed ID: 17289562
[TBL] [Abstract][Full Text] [Related]
19. The roles of LSD1-mediated epigenetic modifications in maintaining the pluripotency of bladder cancer stem cells.
Lan W; Zhang D; Jiang J
Med Hypotheses; 2013 Nov; 81(5):823-5. PubMed ID: 24064254
[TBL] [Abstract][Full Text] [Related]
20. TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapy.
Zheng YC; Yu B; Chen ZS; Liu Y; Liu HM
Epigenomics; 2016 May; 8(5):651-66. PubMed ID: 27102879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
